ORILISSA
Identification of Orilissa
| No description |
Google image searchProduct monograph
Active ingredient
elagolix (elagolix sodium), 200 MG
DIN: 02481340
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 24-MAY-2019
ATC:
- H01 — PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, ATC/DDD, )
- H01C — HYPOTHALAMIC HORMONES (ATC, ATC/DDD)
- H01CC — Anti-gonadotropin-releasing hormones (ATC, ATC/DDD)
- H01CC03 — ELAGOLIX (ATC/DDD)
Reference brand drug: Orilissa
